news – Page 23 – Medxy AI

Prior Traumatic Brain Injury and Alzheimer Disease Blood Biomarkers: Diagnostic Challenges and Clinical Implications

By MedXY 07/01/2026

This review examines the impact of traumatic brain injury on the accuracy of Alzheimer disease blood biomarkers, highlighting reduced diagnostic performance in TBI-affected populations and the implications for clinical interpretation.

Neurology news Rheumatology

Unraveling the Genetic Basis of Spontaneous Spinal CSF Leaks: Insights from Rare Variant Sequencing and Functional Models

By MedXY 07/01/2026

Rare deleterious variants in FBN2 gene contribute to spontaneous spinal CSF leaks, expanding our understanding of connective tissue involvement and opening paths for genetic testing and tailored therapies.

Diabetes & Endocrinology news Ophthalmology

Stimulating Thyrotropin Receptor Antibodies Amplify Fibroblast Expression of TSH and IGF-1 Receptors: Insights into Thyroid Eye Disease Pathogenesis

By MedXY 07/01/2026

Stimulating TSH receptor antibodies enhance expression of TSHR and IGF-1R in fibroblasts via receptor recycling, elucidating mechanisms underlying thyroid eye disease and identifying potential therapeutic targets.

Clinical Updates news

Integrated Intraocular and Plasma Proteomics Identify Neurofilament Light Chain as a Conserved Biomarker for Diabetic Retinopathy Progression: A Multi-Fluid Biopsy Perspective

By MedXY 07/01/2026

This review synthesizes evidence on neurofilament light chain (NFL) as a minimally invasive plasma biomarker predictive of diabetic retinopathy progression and vascular complications, based on integrated intraocular-plasma proteomics and multi-cohort validations.

Cardiology Diabetes & Endocrinology news

Continuous Glucose Monitoring-Derived Time in Range Predicts Longitudinal Changes in Arterial Stiffness in Type 2 Diabetes

By MedXY 07/01/2026

This study demonstrates that continuous glucose monitoring-derived time in range (TIR) is independently associated with progression of arterial stiffness in type 2 diabetes, highlighting TIR as a valuable metric beyond HbA1c for cardiovascular risk management.

Diabetes & Endocrinology Nephrology news

Continuous Glucose Monitoring and Survival Benefits in Diabetic Veterans on Dialysis: Insights from a Nationwide Cohort

By MedXY 07/01/2026

Among U.S. veterans with diabetes on dialysis, continuous glucose monitoring (CGM) use was associated with significantly lower mortality risk compared to non-CGM use, highlighting CGM's potential to improve survival in this high-risk population.

Cardiology Clinical Updates news

AAVrh.10hFXN Gene Therapy for Friedreich Ataxia Cardiomyopathy: Safety and Preliminary Efficacy in a Nonrandomized Clinical Trial

By MedXY 07/01/2026

This review synthesizes evidence from a pioneering nonrandomized trial demonstrating that intravenous AAVrh.10hFXN gene therapy is safe and may improve cardiac outcomes in Friedreich ataxia cardiomyopathy, highlighting translational advances in precision cardiac gene therapy.

Cardiology news Pathology & Lab Medicine/Bệnh học

Beyond Granulomas: Unraveling Cardiac Sarcoidosis with Spatial Proteomics

By MedXY 07/01/2026

Spatial proteomics reveals immune and metabolic heterogeneity in cardiac sarcoidosis, identifying new diagnostic protein signatures beyond granulomatous lesions.

Cardiology news Public Health

Decoding the Cardiovascular Risks of PM2.5 Components: Insights from a Half-Million Chinese Adults Cohort Study

By MedXY 07/01/2026

This large-scale study links specific PM2.5 components, especially chloride, black carbon, and sulfate, to increased long-term cardiovascular disease risk, emphasizing targeted pollution control for better heart health.

Cardiology news

Pulsed Field Ablation Versus Sham Procedure in Atrial Fibrillation: Insights from the PFA-SHAM Randomized Clinical Trial

By MedXY 07/01/2026

This sham-controlled trial demonstrates that pulsed field ablation significantly reduces atrial fibrillation recurrence, burden, and improves quality of life and psychological distress compared to sham treatment.

news Plastic Surgery Public Health

Enhanced Traceability of Breast Implants: Evaluating the Dutch Breast Implant Registry’s Superiority Over Electronic Patient Records in a Test Recall

By MedXY 07/01/2026

A test recall study demonstrated that the Dutch Breast Implant Registry significantly outperforms electronic patient records alone in tracing breast implants, underlining the critical role of comprehensive registries in patient safety.

Neurology news Psychiatry

Unraveling Dementia in Severe Schizophrenia: Distinct Cognitive Profiles and Genetic Insights

By MedXY 06/30/2026

This study reveals that dementia in severe, treatment-resistant schizophrenia exhibits a unique cognitive profile distinct from common neurodegenerative dementias and lacks typical genetic markers such as APOE4, highlighting a novel dementia phenotype in this population.

Critical Care Infectious Diseases news

Therapeutic Implications of MARS Therapy-Induced Piperacillin Clearance in Critical Liver Failure Patients

By MedXY 06/30/2026

MARS therapy significantly reduces total plasma piperacillin levels by approximately one-third per session in critically ill liver failure patients, underscoring the need for therapeutic drug monitoring and individualized antibiotic dosing.

Emergency Medicine news

Embracing Uncertainty: Integrating Palliative Care into Emergency Medicine Practice

By MedXY 06/30/2026

Palliative care in emergency medicine is a vital approach focused on early needs recognition, compassionate communication during uncertainty, and sustained clinical presence to aid decision-making and improve patient and family support.

Internal Medicine news Radiology

Rising Hospital Imaging Use Without Increased Patient Complexity: Insights from General Internal Medicine Admissions 2017-2022

By MedXY 06/30/2026

From 2017 to 2022, general internal medicine inpatient volume increased notably, yet patient complexity remained stable; however, imaging utilization surged, highlighting evolving resource demands in hospital care.

Internal Medicine Nephrology news

The Impact of APOL1 Genotype on Kidney Function After Living Donation in Black Donors

By MedXY 06/30/2026

APOL1 high-risk genotypes significantly increase the risk of reduced kidney function after living kidney donation in Black donors, highlighting the need for genotype screening to improve donor risk stratification.

Diabetes & Endocrinology news

Expanding Technology-Enabled, Nurse-Delivered Chronic Disease Care: A Pragmatic, Randomized, Effectiveness-Implementation Trial

By MedXY 06/30/2026

This study evaluates comprehensive nurse-led telehealth for uncontrolled type 2 diabetes and hypertension in a fee-for-service setting, finding limited improvement in HbA1c but identifying key barriers to implementation.

Hematology-Oncology news Oncology

Unified Conditioning and GVHD Prophylaxis with Fludarabine, Cyclophosphamide, and 2 Gy TBI plus Post-Transplant Cyclophosphamide in Elderly AML/MDS Patients Undergoing Haploidentical or Unrelated Donor Allo-SCT

By MedXY 06/30/2026

Fludarabine, cyclophosphamide, and low-dose TBI combined with post-transplant cyclophosphamide provide a safe and effective single platform for haploidentical and unrelated donor allo-SCT in older AML/MDS patients, showing favorable survival and GVHD outcomes.

Hematology-Oncology news Pathology & Lab Medicine

Decoding CD79B Expression Gradient in Diffuse Large B-Cell Lymphoma: Implications for Germinal Center B-Cell Differentiation and Therapeutic Targeting

By MedXY 06/30/2026

CD79B expression in diffuse large B-cell lymphoma (DLBCL) exhibits a distinct gradient aligned with cell-of-origin subtypes and germinal center B-cell differentiation stages, highlighting the biological basis for differential therapy responses.

Allergy & Immunology Hematology-Oncology news

Unraveling Immune Dysfunction in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: The Role of Systemic Antiviral Loss and Myeloid Suppression

By MedXY 06/30/2026

EBV-positive diffuse large B-cell lymphoma exhibits severe systemic antiviral T-cell impairments and a suppressive tumor microenvironment driven by LMP1, revealing novel immunobiological insights with therapeutic implications.